Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
28m agoVornado Realty Trust to Purchase 49% Interest in Park Avenue Plaza from Closer Properties
28m agoBain Capital Specialty Finance, Inc. Schedules Earnings Release for the First Quarter Ended March 31, 2026
29m agoStoneridge's MirrorEye® Camera Monitor System Continues Strong Momentum, Achieving Record Global Sales and Production Milestones
29m agoAtico Mining Produces 2.09 Million Pounds of Cu and 2,108 Ounces of Au in First Quarter 2026
29m agoMarkel Group reports 2026 first quarter results
Ac Immune Ltd logo

Ac Immune Ltd

About

Ac Immune Ltd (NASDAQ:ACIU) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 7 2026
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly
Mar 19 2026
AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026
Mar 13 2026
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update
Mar 5 2026
AC Immune Announces Upcoming Industry Symposium on Parkinson’s Disease and Presentation at AD/PD™ 2026
Feb 24 2026
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor

Financials

Revenue
$3.57 M
Market Cap
$280.9 M
EPS
-0.88

Community Chat

Ask AI

6ix6ix